Picture of Avrobio logo

AVRO Avrobio Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual income statement for Avrobio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Total Revenue00000
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses18.446.275.8120119
Operating Profit-18.4-46.2-75.8-120-119
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-18.6-46.4-73-120-119
Provision for Income Taxes
Net Income After Taxes-18.6-46.4-73-120-119
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-18.6-46.4-73-120-119
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-18.7-48.6-73-120-119
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.84-2.04-2.66-3.31-2.78
Dividends per Share

Or unlock with your email

Or unlock with your email